AcuFocus, a US-based manufacturer of implants to treating vision loss, has raised $21m from investors incluing medical device maker Medtronic in an oversubscribed round of funding.
Venture capital firms Accuitive Medical Ventures, SV Life Sciences, Versant Ventures and Carlyle Group, and private equity firm Cowen HealthCare Royalty also participated in the round.
AcuFocus develops corneal inlays for treating near-vision loss. The new funding will enable the company to further expand into European markets as it awaits approval for its Kamra technology from the US Food and Drug Administration.
The company, founded in 2001 through medical device incubator Innnovation Factory, raised $65m in 2011 from Medtronic, Cowen, Versant , SV Life Sciences, Carlyle Group, Bausch & Lomb and Accuitive Medical Ventures.